September 12, 2025 - 03:41

Expedition Technology has announced a significant investment from Razor’s Edge and Enlightenment Capital aimed at propelling its expansion within the Signals Intelligence (SIGINT) and Geospatial Intelligence (GEOINT) sectors. This influx of capital is set to enhance the company’s capabilities and accelerate the development of innovative solutions that cater to the evolving needs of defense and intelligence agencies.
With the increasing demand for advanced technologies in national security, Expedition Technology is poised to leverage this investment to enhance its research and development efforts. The funding will enable the company to expand its workforce, invest in cutting-edge technology, and develop new products that improve data processing and analysis for intelligence operations.
The collaboration with Razor’s Edge and Enlightenment Capital underscores the confidence these investors have in Expedition Technology's vision and potential. As the company aims to solidify its position as a leader in the SIGINT and GEOINT markets, this strategic investment marks a pivotal step towards achieving its ambitious growth objectives.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...